Ionis pharmaceuticals stock quote

Author: sfoc

August undefined, 2024

WebIONIS PHARMACEUTICALS, INC. : Historical Intraday Market Prices IONS US4622221004 MarketScreener Homepage Equities Switzerland Berne Stock Exchange Ionis Pharmaceuticals, Inc. Quotes Transaction History IONS US4622221004 IONIS PHARMACEUTICALS, INC. (IONS) Add to my list Report Summary Quotes News … Web13 apr. 2024 · Ionis Pharmaceuticals, Inc. (IONS) Stock Price Today, Quote & News Seeking Alpha IONS Ionis Pharmaceuticals, Inc. Stock Price & Overview 32.52K followers $37.27 0.68 ( +1.86%)...

Ionis Pharmaceuticals IONS Stock Price, Company Overview

Web16 mrt. 2024 · IONS support price is $33.58 and resistance is $34.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IONS stock will trade within this expected range on the day. WebIonis Pharmaceuticals Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $35.48 +1.19 (+3.47%) Updated Mar 29, 2024 1W + 0.54% 1M - 1.17% 3M - 5.01% 1Y - 2.74% IONS Price $35.48 Fair Value Price $37.43 Market Cap $5.07B 52 Week Low $31.46 52 Week High $48.82 P/E -18.67x P/B 8.85x P/S 9.12x PEG N/A Dividend … bing price predictor

IONIS PHARMACEUTICALS, INC. : All Information and News

WebCompare with up to 5 Stocks. On Monday 04/10/2024 the closing price of the Ionis Pharmaceuticals Inc share was $36.91 on NAS. Compared to the opening price on … WebSummary Additional Data Analysts Historical Quotes. Key Data. Previous Close. 36.59. Open. 36.70. Day’s Range. 36.41 x ... In December 2024 we talked about how Ionis … WebIonis Pharmaceuticals stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Ionis Pharmaceuticals … bing price comparison

Ionis pharmaceuticals stock quote

IONIS PHARMACEUTICALS, INC. : Top Mutual Funds Holders

Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high of $67.00 and a low of $27.00.... WebMs. Cadoret-Manier is executive vice president, chief global product strategy and operations officer at Ionis Pharmaceuticals. She is a member of Ionis’ executive leadership team, …

Did you know?

WebIonis Pharmaceuticals stock price target cut to $76 from $90 at BMO Capital Mar. 23, 2024 at 8:51 a.m. ET by Tomi Kilgore Biotech and Pharma Ionis Stock Plunges as … Web10 apr. 2024 · Ionis Pharmaceuticals (IONS) Quote Overview ... Simply put, stocks with a Zacks Rank of 1, 2, or 3, with a positive ESP were shown to positively surprise 70% of …

Web1 dag geleden · Ionis Pharmaceuticals (IONS) (Real Time Quote from BATS) $37.64 USD +1.05 (2.87%) Updated Apr 13, 2024 01:26 PM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: D Value D Growth B... WebFind the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high … WebIonis Pharma Inc (IONS): View stock price & news on TradeStation to help you make better trading & investing decisions. ... The arrow represents the current price quote …

Web29 mrt. 2024 · As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and …

WebIonis Pharmaceuticals, Inc. (IONS) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 2 hours 56 minutes S&P Futures (+0.45%) Dow Futures 33,065.00 … bing pricelineWebWith Ionis Pharmaceuticals stock trading at $35.48 per share, the total value of Ionis Pharmaceuticals stock (market capitalization) is $5.07B. Ionis Pharmaceuticals stock … d5lr and ceftriaxoneWebIonis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and … d5 lady\u0027s-thumbWeb9 aug. 2024 · Ionis Pharmaceuticals kept its 2024 outlook intact Tuesday despite a broad second-quarter miss, and IONS stock dropped below a buy point. X The biotech … d5k cat specsWeb14 aug. 2024 · Shares Sold Short 7.66 M Change from Last -6.15% Percent of Float 5.51% Stock Money Flow N/A PROFILE ( IONS) Ionis Pharmaceuticals, Inc. engages in the … d. 5 hours class 72 nd upperwestsideWeb11 feb. 2024 · CARLSBAD, Calif., Feb. 11, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that the European Medicines Agency (EMA) has granted orphan drug designation to ION373 for the treatment of people with Alexander disease, a severe, progressive and debilitating … d5lr for hypoglycemiaWebBerne Stock Exchange Ionis Pharmaceuticals, Inc. News Press Releases IONS US4622221004 IONIS PHARMACEUTICALS, INC. (IONS) Add to my list Report Summary Quotes News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco. Other languages Press Releases … d5lr with kcl